GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
R&D Expense Growth
104.85%
Quarterly · Period ending:
GSK R&D Expense Growth
Latest reported104.85%period ending
Latest reported104.85%period ending
GSK Quarterly R&D Growth (QoQ) (0.00% → 104.85%)
Latest values, visible window
High-resolution chart · PNG
GSK r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 10.2521% | |
| -18.3813% | |
| 14.0845% | |
| 3.5656% | |
| 14.0481% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |